Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phage Therapy | 9 | 2026 | 50 | 1.970 |
Why?
|
| Bacteriophages | 10 | 2026 | 101 | 1.700 |
Why?
|
| Bacillus anthracis | 6 | 2021 | 45 | 1.040 |
Why?
|
| Escherichia coli Infections | 3 | 2026 | 194 | 0.840 |
Why?
|
| Urinary Tract Infections | 3 | 2026 | 335 | 0.840 |
Why?
|
| Blood Proteins | 2 | 2021 | 143 | 0.460 |
Why?
|
| Serum | 1 | 2015 | 41 | 0.440 |
Why?
|
| Anthrax | 3 | 2020 | 33 | 0.430 |
Why?
|
| Amino Acids | 1 | 2015 | 563 | 0.370 |
Why?
|
| Bacterial Proteins | 6 | 2020 | 943 | 0.370 |
Why?
|
| Bacterial Infections | 3 | 2025 | 327 | 0.360 |
Why?
|
| Bacteria | 3 | 2026 | 521 | 0.310 |
Why?
|
| Anti-Bacterial Agents | 6 | 2025 | 2573 | 0.290 |
Why?
|
| Anthrax Vaccines | 2 | 2020 | 28 | 0.280 |
Why?
|
| Heme | 2 | 2019 | 46 | 0.250 |
Why?
|
| Uropathogenic Escherichia coli | 1 | 2026 | 26 | 0.230 |
Why?
|
| Escherichia coli | 2 | 2021 | 981 | 0.220 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2024 | 60 | 0.200 |
Why?
|
| Iron | 3 | 2015 | 305 | 0.200 |
Why?
|
| Pseudomonas Phages | 1 | 2023 | 11 | 0.200 |
Why?
|
| Poliovirus | 1 | 2023 | 47 | 0.200 |
Why?
|
| Probiotics | 1 | 2025 | 226 | 0.180 |
Why?
|
| HIV-1 | 1 | 2026 | 494 | 0.180 |
Why?
|
| Pseudomonas Infections | 1 | 2023 | 117 | 0.180 |
Why?
|
| Hydro-Lyases | 1 | 2021 | 12 | 0.180 |
Why?
|
| Bacillus | 1 | 2021 | 37 | 0.180 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2021 | 848 | 0.170 |
Why?
|
| Carbon | 1 | 2021 | 100 | 0.170 |
Why?
|
| Virulence | 1 | 2021 | 268 | 0.170 |
Why?
|
| Extraintestinal Pathogenic Escherichia coli | 1 | 2021 | 25 | 0.160 |
Why?
|
| Antibodies, Bacterial | 2 | 2020 | 405 | 0.160 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2021 | 166 | 0.160 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 242 | 0.160 |
Why?
|
| Transplant Recipients | 1 | 2021 | 230 | 0.150 |
Why?
|
| Culture Media | 2 | 2021 | 169 | 0.150 |
Why?
|
| Prosthesis-Related Infections | 1 | 2021 | 194 | 0.150 |
Why?
|
| Cities | 3 | 2024 | 51 | 0.150 |
Why?
|
| Metabolome | 1 | 2021 | 325 | 0.140 |
Why?
|
| Hemoglobins | 2 | 2021 | 285 | 0.140 |
Why?
|
| Antigens, Bacterial | 1 | 2020 | 318 | 0.140 |
Why?
|
| Precision Medicine | 1 | 2021 | 382 | 0.140 |
Why?
|
| Zinc | 2 | 2015 | 127 | 0.130 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2025 | 828 | 0.130 |
Why?
|
| Humans | 21 | 2026 | 130066 | 0.130 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 523 | 0.120 |
Why?
|
| Metalloproteins | 1 | 2015 | 11 | 0.120 |
Why?
|
| Aminoacyltransferases | 1 | 2015 | 9 | 0.120 |
Why?
|
| Protein Sorting Signals | 1 | 2015 | 44 | 0.110 |
Why?
|
| Cysteine Endopeptidases | 1 | 2015 | 109 | 0.110 |
Why?
|
| HIV Infections | 1 | 2026 | 2046 | 0.100 |
Why?
|
| Animals | 10 | 2026 | 33641 | 0.100 |
Why?
|
| Heart-Assist Devices | 1 | 2021 | 1018 | 0.090 |
Why?
|
| Liver Transplantation | 1 | 2021 | 1136 | 0.090 |
Why?
|
| Cattle | 2 | 2024 | 500 | 0.090 |
Why?
|
| TRPM Cation Channels | 1 | 2011 | 12 | 0.090 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 2392 | 0.080 |
Why?
|
| Metals | 1 | 2011 | 69 | 0.080 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3464 | 0.080 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2021 | 156 | 0.070 |
Why?
|
| Lysosomes | 1 | 2011 | 264 | 0.070 |
Why?
|
| Mice | 5 | 2026 | 18144 | 0.070 |
Why?
|
| Heart Failure | 1 | 2021 | 2325 | 0.070 |
Why?
|
| Genome, Viral | 1 | 2026 | 167 | 0.060 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2026 | 376 | 0.050 |
Why?
|
| Livestock | 1 | 2024 | 11 | 0.050 |
Why?
|
| Pandemics | 2 | 2023 | 1113 | 0.050 |
Why?
|
| Farmers | 1 | 2024 | 13 | 0.050 |
Why?
|
| Birds | 1 | 2024 | 48 | 0.050 |
Why?
|
| Influenza in Birds | 1 | 2024 | 27 | 0.050 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2024 | 56 | 0.050 |
Why?
|
| Epidemiological Monitoring | 1 | 2024 | 69 | 0.050 |
Why?
|
| Protein Conformation | 2 | 2016 | 732 | 0.050 |
Why?
|
| Vagina | 1 | 2026 | 207 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2020 | 996 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2016 | 1060 | 0.050 |
Why?
|
| Cephalosporins | 1 | 2023 | 135 | 0.050 |
Why?
|
| Biofilms | 1 | 2023 | 91 | 0.050 |
Why?
|
| Phylogeny | 1 | 2024 | 684 | 0.050 |
Why?
|
| Water | 1 | 2023 | 185 | 0.040 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2023 | 176 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2023 | 311 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2026 | 905 | 0.040 |
Why?
|
| Middle Aged | 1 | 2021 | 28314 | 0.040 |
Why?
|
| Genetic Fitness | 1 | 2021 | 34 | 0.040 |
Why?
|
| Adaptation, Biological | 1 | 2021 | 31 | 0.040 |
Why?
|
| Cell Line | 1 | 2026 | 2551 | 0.040 |
Why?
|
| Microbial Viability | 1 | 2021 | 43 | 0.040 |
Why?
|
| Blood | 1 | 2021 | 98 | 0.040 |
Why?
|
| Public Health | 1 | 2023 | 269 | 0.040 |
Why?
|
| Drug Antagonism | 1 | 2020 | 13 | 0.040 |
Why?
|
| Complement C5 | 1 | 2020 | 6 | 0.040 |
Why?
|
| Freund's Adjuvant | 1 | 2020 | 20 | 0.040 |
Why?
|
| Alum Compounds | 1 | 2020 | 41 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2020 | 236 | 0.040 |
Why?
|
| Administration, Inhalation | 1 | 2020 | 192 | 0.040 |
Why?
|
| Virulence Factors | 1 | 2021 | 180 | 0.040 |
Why?
|
| Mixed Function Oxygenases | 1 | 2019 | 36 | 0.040 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2020 | 124 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2024 | 1690 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2021 | 766 | 0.040 |
Why?
|
| Influenza, Human | 1 | 2024 | 703 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2021 | 477 | 0.030 |
Why?
|
| Metabolomics | 1 | 2021 | 499 | 0.030 |
Why?
|
| Phagocytes | 1 | 2016 | 25 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2020 | 1481 | 0.030 |
Why?
|
| Female | 4 | 2026 | 70239 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 2016 | 185 | 0.030 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2015 | 42 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2016 | 779 | 0.030 |
Why?
|
| Male | 1 | 2021 | 64378 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2026 | 4637 | 0.030 |
Why?
|
| Protein Binding | 1 | 2019 | 1649 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2015 | 285 | 0.030 |
Why?
|
| Vaccination | 1 | 2020 | 1052 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2023 | 17537 | 0.030 |
Why?
|
| Texas | 1 | 2023 | 3655 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2015 | 252 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2020 | 3807 | 0.020 |
Why?
|
| Mucolipidoses | 1 | 2011 | 7 | 0.020 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2011 | 20 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 6401 | 0.020 |
Why?
|
| Biological Transport | 1 | 2011 | 328 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2025 | 12818 | 0.020 |
Why?
|
| Cell Survival | 1 | 2011 | 827 | 0.020 |
Why?
|
| Mutation | 1 | 2021 | 6068 | 0.020 |
Why?
|
| Aged | 1 | 2025 | 20820 | 0.020 |
Why?
|
| Calcium | 1 | 2011 | 1008 | 0.010 |
Why?
|